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Abstract
Obesity, which is largely due to energy imbalance, has emerged as one of the most serious health issues in the world. The hypothalamus is the most important organ 
to regulate feeding behavior and energy expenditure through nutrient sensing and signal integration from central and peripheral pathways. As the main organelle 
to produce energy, mitochondria play a critical role in energy homeostasis from the organelle level. Besides providing a platform for the oxidation of fuel substrates, 
mitochondria are also involved in a variety of cell signaling pathways and modulate energy homeostasis through mitochondrial dynamics. Mitochondrial dysfunction 
may lead to obesity due to inadequate ATP production, oxidative stress, endoplasmic reticulum stress, and inflammation. β, β-carotene-9’,10’-oxygenase2 (BCO2) 
is a mitochondrial enzyme that catalyzes the asymmetric cleavage of both provitamin A and non-provitamin A carotenoids. This enzyme is localized to the inner 
mitochondrial membrane, where the electron transport chain is located. Besides the enzymatic function, BCO2 is important for mitochondrial function and is 
genetically associated with interleukin-18. Moreover, BCO2 protein expression is suppressed in obese and diabetic mice. Given that the important role of BCO2 in 
mitochondrial structure and function, and the key position of the hypothalamus in energy balance, BCO2 may play a new role in maintaining metabolic homeostasis 
that has been overlooked before. The mutation of BCO2 might lead to the impairment of whole body energy homeostasis through hypothalamic mitochondrial 
dysfunction. Here we will be presenting the updates on hypothalamic mitochondria in cellular energy homeostasis and discussing the potential of BCO2 in regulation 
of hypothalamic mitochondria in health and obesity.   
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Introduction 
Obesity has emerged as one of the most serious health issues in the 
world, which  is closely related to type-2 diabetes [1], neurodegenerative 
diseases [2], cardiovascular disease [3], and some forms of cancer [4,5]. 
Obesity is the result of energy intake exceeding energy expenditure. It 
is a disorder of energy balance [6] commonly caused by a combination 
of excessive food intake, lack of physical activity , and genetic 
susceptibility [7]. 
The hypothalamus is a key region in brain for modulating 
feeding behavior and energy expenditure through nutrient sensing 
and signal integration from central and peripheral pathways [8-10]. 
Two populations of neurons in the arcuate nucleus (ARC) of the 
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hypothalamus play an important role in maintaining energy balance. 
One population of neurons express anorexigenic proopiomelanocortin 
(POMC) and the other express orexigenic agouti-related protein 
(AgRP)/neuropeptide Y (NPY). POMC and NPY/AgRP neurons 
could respond to leptin and insulin and interact with gut hormones 
such as ghrelin, glucagon-like peptide-1 (GLP-1), peptide YY3–36, 
cholecystokinin, and pancreatic polypeptide to maintain energy 
balance [10,11].
Hypothalamic mitochondria are involved in the modulation 
of energy balance by mitochondrial dynamic to modulate AGRP 
and POMC neuronal activity [12,13]. Mitochondria could change 
their number and size by fusion and fission to adapt to the energy 
environment [12]. It was reported that mitochondria could fuse in 
AgRP neurons, and fission in POMC neurons during a positive energy 
balance to enable sustained neuronal activity and maximize the uptake 
of energy. The morphology of mitochondria also differs between 
obese and lean mice. Reduced mitochondrial length and loss of 
mitochondria- endoplasmic reticulum (ER) interactions were observed 
in diet-induced obese mice compared to lean controls [13]. 
The mitochondria are responsible for most of the ATP 
production in the cell through the electron transport chain (ETC)/
oxidative phosphorylation (OXPHOS). These processes occur in 
the inner membrane of mitochondria. The ATP producing capacity 
of mitochondria is another factor that affects energy homeostasis. A 
reduced ATP level in the hypothalamus leads to persistent AMPK 
stimulation. Leptin could function through inhibition of hypothalamic 
AMPK signaling to increase energy expenditure and lower food 
intake. Therefore, sustained AMPK stimulation requires a high level of 
leptin to suppress the effects of AMPK on AgRP and NPY [14]. Such 
impairment in ATP formation would lead to the tendency of eating 
more than what the body needs and conserving energy by lowering 
energy expenditure. 
BCO2 (β, β-carotene-9’,10’-oxygenase2) is an enzyme that catalyzes 
the asymmetric cleavage of carotenoids in the inner membrane 
of mitochondria [15]. Recent controversial research findings 
demonstrated that BCO2 may not be activated in the human macula 
where carotenoids preferentially accumulate [16,17], suggesting that 
BCO2 may not only function as a carotenoid cleavage enzyme which 
warrants further investigation. For example, BCO2 is involved in 
inflammation by regulating the transcription of the IL-18 gene [18]. 
It also participates in macular degeneration in humans [16] and in the 
process of anemia and apoptosis of red blood cells in zebrafish [19]. 
Furthermore, BCO2 protein expression is reduced in obese [20] and 
diabetic mice [21]. However, how BCO2 impacts these processes, 
whether in a direct or an indirect manner, is still unknown.   
The expression and activity of BCO2 have been verified in humans 
[22], mice [23], rats [24], cattle [25], chickens [26], and sheep [27]. 
BCO2 is expressed in many types of cells, such as liver hepatocytes, 
epithelial cells of villi and endothelial cells in the duodenum of the 
small intestine, and other tissues such as kidney and lungs [28-30]. 
Recently, BCO2 was found to be in the inner mitochondrial membrane 
[31], where complexes of the ETC/OXPHOS are located. In accordance 
with this finding, carotenoids were found to be accumulated in 
the mitochondria of BCO2 knockout mice, which further led to 
mitochondrial dysfunction, indicated by an increased manganese 
superoxide dismutase (SOD2) level and decreased respiratory activity 
[23]. Given that the key position of the hypothalamus in energy balance 
and the potential role of BCO2 in mitochondrial function, BCO2 may 
play a novel function in maintaining metabolic homeostasis in the 
hypothalamus. 
The predominant role of the hypothalamus in mediating 
energy homeostasis
Obesity refers to the metabolic state in which excess fat is 
accumulated in peripheral tissues, such as white adipose tissue, liver, 
and muscle [32]. Obesity, which has negative effects on both the quality 
and length of life, is commonly caused by a combination of excessive 
food intake, lack of physical activity, and genetic susceptibility [7,33]. 
The hypothalamus plays a significant role in controlling energy 
expenditure and food intake, which are the determinants of metabolic 
phenotype.
The hypothalamus is organized into anatomically discrete 
nuclei: paraventricular nucleus (PVN), lateral hypothalamic area 
(LHA), dorsomedial hypothalamic nucleus (DMH), ventromedial 
hypothalamus (VMH), and ARC [34]. These neuronal clusters form 
interconnected neuronal circuits to sense information inputs from 
the process of eating, ingestion, absorption, and metabolism, as well 
as the change of energy storage [34]. Early hypothalamic lesioning 
experiments showed the LHA acts as the “hunger center” and is 
associated with hypophagia and loss of body weight, while the VMH 
is the ‘satiety center’ and is linked to hyperphagia and obesity [35]. The 
ARC is located in the basal part of the hypothalamus and is in close 
contact with the median eminence. The ARC could sense fluctuations 
in signals from hormones, nutrients, and other molecules that are 
transported within the blood [8]. Thus the ARC has been postulated 
to play a fundamental role in sensing the global energy status of the 
organism [8,9] and integrating signals from central and peripheral 
pathways [10]. 
The POMC and AgRP/NPY are expressed by two key populations 
of neurons that have opposite effects on appetite in the ARC. POMC 
neurons exert an anorexigenic effect by co-expressing POMC and 
cocaine- and amphetamine-regulated transcript (CART) [34]. POMC 
is the precursor of α-melanocyte stimulating hormone (α-MSH), which 
could activate melanocortin 4 receptors (MC4R). Activation of MC4R 
would ultimately inhibit appetite and increase energy expenditure 
[36]. The other population of neurons co-express orexigenic NPY and 
AgRP. NPY exerts an orexigenic effect via different subtypes of NPY 
receptors on downstream neurons, while AgRP could directly block 
α-MSH action [36]. Both of these populations of neurons act on the 
PVN, and the ARC also interacts with other hypothalamic nuclei such 
as the LHA, VMH, and DMH [37]. 
Hypothalamus regulates energy homeostasis through 
circulating hormones
NPY/AgRP and POMC/CART neurons respond to a variety of 
circulating hormones to regulate energy balance. Insulin and leptin are 
the two most critical anorexigenic hormones that are involved in energy 
homeostasis [38]. The activation of leptin and insulin are mediated by 
their receptors in the central nervous system (CNS). Leptin receptor 
(LepR) and insulin receptor (InsR) are highly expressed in the AgRP 
and POMC neurons of the ARC [39]. 
Leptin is a hormone secreted from white adipose tissue and 
circulates through the body in proportion to body fat mass. It plays a 
major role in energy homeostasis by inhibiting food intake, enhancing 
lipolysis, decreasing lipogenesis, and elevating energy expenditure. 
Leptin acts via LepR in the hypothalamus (predominantly the VMN 
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and ARC, but also the choroid plexus) to regulate energy balance and 
neuroendocrine function [40-42]. The POMC neurons are activated by 
leptin, resulting in α-MSH release from POMC axon terminals. The 
α-MSH could further activate MC4R to increase energy expenditure 
and suppress food intake [43]. At the same time, the activity of 
NPY/AgRP neurons is inhibited by leptin [44]. Otherwise, it would 
antagonize the effect of α-MSH on MC4Rs through the release of AgRP 
[45]. Besides the actions of leptin via the brain, energy expenditure 
and food intake could also be modified through the direct action of 
LepRs on a peripheral target, including the β cells of the pancreas, liver, 
muscle, and fat [46].
Insulin is secreted by pancreatic β-cell in response to increased 
plasma glucose levels. It promotes energy utilization and storage 
through the regulation of glucose uptake and the metabolism of 
fatty acids. In skeletal muscle, insulin promotes glucose uptake by 
stimulating the movement of intracellular vesicles containing GLUT4 
from cytosol to the plasma membrane, which increases the transport 
capacity of glucose. In adipose tissue, insulin reduces free fatty acid 
(FFA) efflux from adipocytes, thus decreasing lipolysis and facilitating 
fat storage. Furthermore, insulin promotes the storage of glucose as 
glycogen and/or triacylglycerol in the liver and inhibits hepatic glucose 
production by decreasing the activity of gluconeogenic enzymes [47]. 
Hypothalamic leptin and insulin signaling are involved in both 
short- and long-term energy regulation (Figure 1 (revised from [9])). 
Janus kinase (JAK) is recruited and activated when leptin binds 
to the extracellular domain of LepR-b,. The activated JAK in turn 
helps to phosphorylate LepR-b [48]. During this process, the signal 
transducer and activator of transcription 3 (STAT3) are activated. The 
phosphorylated STAT3 could stimulate POMC and inhibit AgRP [49]. 
The activation of STAT3 is associated with the elevated expression 
of the suppressor of cytokine signaling 3 (SOCS3). SOCS3 will bind 
with the LepR-b-JAK-2 complex, thus inhibits leptin signaling [50]. 
Insulin signaling is initiated by insulin binding to the α subunit of InsR 
[51]. The conformational change of the α subunit exhibits intrinsic 
tyrosine kinase activity, which could activate InsR [52]. The insulin 
receptor substance (IRS) is activated through the phosphorylation 
process resulting from InsR. The leptin signaling and insulin signaling 
converge together through the phosphoinositide 3-kinase (PI3K)– 
Phosphatidylinositol 3,4,5-trisphosphate (PIP3)– 3-phosphoinositide-
dependent protein kinase 1(PDK1)– forkhead box protein O1 (FoxO1) 
signaling pathway [9]. The PI3K, which is activated by leptin or IRS, 
could promote the synthesis of PIP3 [53]. As the PIP3 accumulates, 
PDK1 is activated, which leads to the activation of protein kinase B 
(PKB, also known as AKT). Within the nucleus, FoxO1 could activate 
AgRP and inhibit POMC expression [54]. Activation of AKT induces 
the phosphorylation of FoxO1 and further leads to the export of 
FoxO1 into the cytoplasm. This would facilitate STAT3 to bind 
with POMC/AgRP. AKT also functions to activate the mammalian 
target of rapamycin (mTOR), and the activation of mTOR involves 
phosphorylation and inhibition of adenosine monophosphate (AMP)-
activated protein kinase (AMPK). Both mTOR and AMPK act as 
sensors of the nutrient status that is involved in the regulation of food 
intake and energy expenditure, which will be discussed below.
Most obese patients are associated with high serum leptin levels. 
This situation is called leptin resistance. Similarly, insulin resistance 
is characterized by a decreased ability to respond to insulin. In most 
cases, impaired insulin sensitivity of the target organs, rather than 
the low insulin level in the body, eventually leads to type 2 diabetes. 
Activation of the IκB kinaseβ (IKK), c-Jun N-terminal kinase (JNK), 
and protein kinase C iota (PKCτ) signaling pathways and increased 
expression of SOCS3 and PTP1B are the major molecular mechanisms 
involved in the induction of hypothalamic leptin resistance and insulin 
resistance [55-59]. 
The hypothalamus can also interact with a variety of gut hormones. 
For example, peptide YY3–36, cholecystokinin, GLP-1, oxyntomodulin 
(OXM), and pancreatic polypeptide act synergistically to suppress 
appetite, whereas ghrelin acts to stimulate food intake [10,11]. By 
relaying signals of nutrition level and energy status from the gut to the 
CNS, the interaction between NPY/AgRP and POMC/CART neurons 
and gut hormones plays a critical role in regulating food intake. 
Hypothalamus regulates energy homeostasis through 
sensing nutrient status
Aside from the signals from hormones, the hypothalamus is also 
sensitive to circulating metabolites. Two types of glucosensing neurons 
are either inhibited or excited as the glucose level fluctuates [60]. 
Glucosensing neurons regulate their membrane potential, firing rate, 
and ion channel function to sense ambient glucose. Glucose sensing is 
especially important in stimulating appetite when glucose availability 
drops [61-63].  
Circulating lipids such as triglyceride and long-chain fatty acids 
(LCFAs) function similar to insulin through elevation of the LCFA-
CoA level in the hypothalamus [64]. LCFA gets into the brain by passive 
diffusion or translocation via a carrier protein. Upon entry into the 
neurons, LCFA is esterified into LCFA-CoA via Acetyl-CoA synthetase 
(ACS). LCFA-CoA signals nutrient abundance and exhibits insulin-
like effects in the brain, including the hypothalamic ARC, to modulate 
energy homeostasis [65]. Brain fatty acids act as a satiety signal to 
inhibit appetite [66]. Both the peripheral and central administration of 
a fatty acid synthase inhibitor significantly suppresses appetite [67,68]. 
An in vivo study showed food intake and hepatic glucose production 
were inhibited after three days of intracerebroventricular infusion of 
oleic acid [69]. The accumulation of LCFA-CoA within specific CNS 
neurons could activate catabolic neural pathways to inhibit appetite 
and hepatic glucose production [70]. The anorectic effect of the 
Figure 1. Leptin and insulin signaling pathways in the hypothalamus (Revised from [9]) 
. Leptin and insulin are secreted from white adipose tissue and the pancreas, respectively. 
They are activated via their receptors in the hypothalamus. The activation of both 
LepR-b and InsR could further activate the PI3K–PIP3–PKD1–FoxO1 signaling pathway. 
Phosphorylation of LepR-b by JAK2 also leads to the recruitment and phosphorylation of 
STAT3. SOCS3 would desensitize leptin signaling by suppressing STAT3 activation. 
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accumulation of LCFA-CoA may lie downstream of the leptin-induced 
inhibition of hypothalamic AMPK [71]. LCFA-CoA in the brain 
activates protein kinase C and further phosphorylates and activates 
ATP-sensitive potassium (KATP) channels. This lipid-sensing pathway 
in the hypothalamus activates N-methyl-d-aspartate (NMDA) receptor 
to trigger the hepatic vagus nerve to regulate glucose production. In 
this way, neuronal signals are transmitted via the hepatic vagus nerve 
to the liver. 
In contrast to intracellular LCFA-CoA accumulation, which is 
a sensor of nutrient abundance, the AMPK is a sensor of nutrient 
insufficiency. At the peripheral level, AMPK activation leads to 
increased oxidation to maintain cellular energy availability. In the 
ARC, AMPK activation results in increased food intake and a trend 
to conserve energy [72]. When cells sense the low fuel availability 
indicated by an increased AMP/ATP ratio, the activation of AMPK 
enhances substrate oxidation to replenish the depleted ATP levels 
[65]. Research conducted in mice showed that within the mediobasal 
hypothalamus, activation of AMPK increased food intake and body 
weight, while inhibition of AMPK led to the opposite results [72]. 
Hypothalamic AMPK activity is inhibited by glucose, insulin, and 
leptin and stimulated by ghrelin [72,73]. The change of AMPK 
signaling may also alter the appetite governed by those hormones. A 
consequence of increased AMPK activity is the oxidation of LCFA-
CoA, which might induce orexigenic effects. Furthermore, AMPK 
could inhibit the activity of mTOR, another nutrient sensor, which will 
be discussed below. 
mTOR is an evolutionarily conserved serine-threonine kinase 
involved in the regulation of cell-cycle progression and growth via 
sensing energy status [74]. It was demonstrated that in peripheral 
tissues, mTOR participates in coupling cellular energy status and 
facilitated cellular anabolic processes, such as protein synthesis in 
response to growth factors, amino acids, glucose, and stress [10]. Later, 
research found that mTOR was also expressed in the hypothalamus 
and to play an important role in hypothalamic regulation of energy 
homeostasis in response to nutrient availability. Cota et al. found that 
administration of leucine in rats led to elevated hypothalamic mTOR 
signaling and decreased food intake, as well as body weight [74]. They 
also showed that leptin could activate hypothalamic mTOR activity 
and that inhibition of mTOR signaling would block the leptin-induced 
suppression of food intake [74]. Both mTOR and AMPK represent a 
potential site of convergence for both hormonal and nutrient sensing. 
The role of mitochondria in maintaining cellular en-
ergy metabolism
We have discussed that the hypothalamus is the most important 
organ to modulate energy homeostasis in brain. When we take a closer 
look at the cell organelle level, the mitochondrion is the key organelle 
that maintains cellular energy metabolism. The mitochondrion is 
a double-membrane bound organelle in most eukaryotic cells [75]. 
It is composed of an outer membrane, intermembrane space, inner 
membrane, and the matrix. A variety of enzymes are involved in 
different metabolic processes in the mitochondrial matrix. One major 
role of a mitochondrion is to produce energy through the tricarboxylic 
acid (TCA) cycle and ETC/OXPHOS. In addition to the utilization 
of the carbohydrate-derived substrate, the β-oxidation of fatty acids 
is another resource to generate ATP that mainly takes place in the 
mitochondria. Besides providing a platform for the oxidation of fuel 
substrates, mitochondria are also involved in a variety of cell signaling 
pathways, such as acting as transducers and effectors in the process 
of cell death, innate immunity, and autophagy [76,77]. Furthermore, 
mitochondria also serve as calcium buffers and sources of free radicals 
[78,79]. 
Hypothalamic mitochondria and energy homeostasis
Hypothalamic mitochondrial dynamic is involved in the energy 
homeostasis through the regulation of AgRP and POMC neuronal 
activity [12,13]. Mitochondrial dynamics refer to the dynamic fission 
and fusion behavior and morphology change of mitochondria [80] in 
response to the environment, especially to the energy status. Mitofusins 
(Mfn) namely, Mfn1 and Mfn2, work coordinately to regulate 
mitochondrial fusion. The depletion of Mfn1 and Mfn2 in AgRP 
neurons of mice led to decreased activity of the AgRP neuron, which 
was accompanied by weight loss. [12]. When mice were deprived of 
food, an increased number and decreased size of mitochondria were 
observed in AgRP neurons [12]. When fasted mice were exposed to 
excess food, the number of mitochondria decreased but their size 
increased in the AgRP neurons. However, the opposite fission-like 
dynamic phenomenon was observed in the POMC neurons, which 
exhibited reduced mitochondrial density and coverage [12]. Similarly, 
mitochondria in the AgRP neurons were fused when mice were fed a 
high-fat diet. These findings indicate that mitochondria could fuse in 
AgRP neurons and fissure in POMC neurons during a positive energy 
balance to enable sustained neuronal activity and maximize the uptake 
of energy.
The morphology of mitochondria also differs between obese and 
lean mice. It has been reported that mitochondrial networks and 
mitochondria-endoplasmic reticulum (ER) contacts in POMC are 
important for energy homeostasis [13]. Mitochondria form tubular 
structures or networks in the cell. The branched structure of the 
mitochondrial network is constituted by separate mitochondria [81]. 
Decreased mitochondrial length and branching was observed in diet-
induced obese mice compared to lean controls. Diet-induced mice also 
showed a significant reduction of mitochondria-ER contacts in POMC 
neurons.
Mitochondria and adipocyte transcription factors 
Some adipocyte transcription factors play a critical role in 
modulating mitochondrial function and biogenesis [82]. The 
peroxisome proliferator-activated receptor gamma coactivator (PGC) 
family is a group of transcriptional coactivators. A reduced PGC-1α 
level was observed in the adipose tissues of obese patients [83] and 
in genetically or diet-induced obese mice [84]. PGC-1α and PGC-1β 
not only participate in the regulation of glucose metabolism, fatty 
acid metabolism, and lipid accumulation, but also function to affect 
the expression of the mitochondrial biogenesis gene and are involved 
in the development of obesity [85]. PGC-1 stimulates mitochondrial 
biogenesis and respiration in myotubes of muscle via an induction of 
uncoupling protein 2 (UCP2), and through the regulation of the nuclear 
respiratory factors (NRFs). Deficiency in either PGC-1α or PGC-
1β in preadipocytes of brown adipose tissue (BAT) led to impaired 
mitochondrial gene expression, density, and respiratory activity [86] .
PR Domain Containing 16 (PRDM16) is the coactivator of PGC-
1α and PGC-1β, which is important for mitochondrial biogenesis 
and uncoupled cellular respiration [87,88]. Decreased PRDM16 
expression in BAT leads to the inhibition of mitochondrial gene 
expression and stimulation of myogenic markers [88,89]. Another 
important transcriptional coactivator is bone morphogenetic protein 
7 (BMP7), a subgroup of the transforming growth factor beta (TGF-β) 
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superfamily, which increases mitochondrial density and the expression 
of mitochondrial biogenesis genes through activation of p38 mitogen-
activated protein kinases (MAPK) and PGC-1a [90].
Mitochondrial dysfunction in the development of 
obesity 
A renaissance in mitochondrial research has occurred during the 
past decade. Besides its function in energy production, mitochondria 
participate in many processes including cell signaling, cell 
differentiation, and apoptosis [81]. Mitochondria are also involved 
in the generation of reactive oxygen species (ROS), ER stress, and 
inflammation. Mitochondrial dysfunction is thought to trigger 
many chronic diseases, including neurodegenerative diseases such 
as Parkinson’s disease and Alzheimer’s disease, liver and kidney 
disorders, diabetes, and the aging process [91]. By integrating such 
metabolic information including ATP level, oxidative stress, ER stress, 
inflammation, and cell signaling, mitochondria play an important role 
during the development of obesity.
Inadequate ATP production and obesity
A possible source of leptin resistance is impaired mitochondrial 
ATP production. Research has shown that altered mitochondrial 
energy production, especially in skeletal muscles, is a major factor 
to disrupt a chain of metabolic events leading to obesity [14]. In the 
hypothalamus, the reduced energy producing capacity of mitochondria 
led to persistently high hypothalamic AMPK stimulation. Leptin 
could function through inhibition of hypothalamic AMPK signaling 
to increase energy expenditure and lower food intake. Therefore, 
sustained AMPK stimulation requires a high level of leptin to suppress 
the regulation of AMPK on AgRP and NPY [14]. Such impairment 
in ATP formation would lead to the tendency of eating more than 
what the body needs and conserving more energy by lowering energy 
expenditure.
Oxidative stress and obesity
Energy is produced from the TCA cycle, ETC/OXPHOS, and 
β-oxidation of fatty acids in the mitochondria. Approximately 
90% of oxygen in the cell is consumed by the mitochondria [92]. 
The mitochondrial respiratory chain is one of the major sources of 
ROS. While mitochondria generate ATP through ETC/OXPHOS, 
ROS is generated as a byproduct [93]. The electrons are transported 
from NADH and FADH2 to complex III, and then to complex IV. 
Eventually, electrons are passed on to oxygen, yielding H2O. However, 
some electrons might escape from ETC. Once these electrons leak into 
the mitochondrial matrix, the incomplete electron transfer will lead to 
the formation of superoxide (O2−⋅). It has been reported that complex 
I is a major donor of electrons to generate ROS in the brain [94]. Even 
under normal physiological conditions, approximately 1–5% of the O2 
consumed by mitochondria is converted to ROS [81]. ROS refer to a 
variety of oxygen free radicals, such as superoxide anion radical (O2−⋅), 
hydroxyl radical (·OH), and non-radical oxidants, such as hydrogen 
peroxide (H2O2) and singlet oxygen (1O2) [95]. Most of the intracellular 
ROS are derived from superoxides.  
ROS are important for various cell functions and act as a mediator 
of intracellular signaling cascades. However, excessive production of 
ROS may cause damage to cells and ultimately lead to the apoptosis 
or necrosis of the cells [96]. Organisms need to maintain equilibrium 
between the ROS produced during the energy generating process 
and the damaging effects of ROS, which is known as oxidative stress 
[81]. Oxidative stress is usually associated with the etiology of obesity, 
type 2 diabetes, cancer, and many other chronic diseases [97,98]. In 
the cells, there are various anti-oxidative enzymes, such as superoxide 
dismutase, copper/zinc superoxide dismutase, glutathione peroxidase, 
and catalase, to deal with the continuous production of ROS [99].
The excess lipid accumulation in obese people represents an 
excess of energy, but obese individuals fatigue easily and show lower 
physical endurance, reflecting an energy deficiency [14]. Continuous 
mitochondrial overload of fuel and incomplete fatty acid oxidation 
could lead to increased ROS production [100,101]. Oxidative stress also 
impairs mitochondrial function, resulting in elevated ROS production 
and mitochondrial dysfunction. This mitochondrial dysfunction may 
in turn induce insulin resistance, resulting in a vicious cycle that 
leads to obesity-related pathogenesis. The elevated ROS level due to 
mitochondrial dysfunction stimulates various downstream pathways 
including  JNK/signal transducers and activators of transcription 
(STAT) pathway, JNK/inhibitor of nuclear factor kappa-B kinase 
(IKKβ), and MAPK, which can disturb leptin and insulin pathways 
[52,102-104]. A decreased number of mitochondria may also lead to 
insulin resistance [52]. Petersen and colleagues demonstrated that 
insulin resistance is caused by dysregulation of cellular fatty acid 
metabolism, which is a result of an inherited defect in mitochondrial 
oxidative phosphorylation [105].
ER stress and obesity
ER, an important organelle that forms an interconnected network, 
is responsible for the synthesis, folding, and maturation of secreted 
and transmembrane proteins; biosynthesis of lipids; and the storage 
of Ca2+ [106,107]. ER stress results from an imbalance between 
the protein folding capacity and the protein load [55]. The direct 
result of ER stress is the accumulation of misfolded protein. The ER 
establishes direct contact with mitochondria through ER domains 
termed mitochondrial-associated membranes (MAMs). MAMs allow 
bidirectional communication and trafficking of a signaling molecule 
[108]. Such association is essential for both mitochondria and ER 
functions. The interaction between the ER and mitochondria is partially 
modulated by mitochondrial fusion and fission [108]. The dysfunction 
of mitochondria is one trigger to ER stress through decreased ATP 
production and the alteration of the mitochondrial membrane 
potential and permeability. Both diet-induced and genetic obesity 
in mice are associated with increased ER stress in the hypothalamus 
[56,109,110]. Hypothalamic ER stress has emerged as a causative factor 
in the development of obesity by inducing leptin resistance and insulin 
resistance.
Enhanced hypothalamic ER stress may play a primary pathogenic 
role in the development of leptin resistance. Schneeberger et al. put 
forward the hypothesis that MFN2 in the POMC is the molecular 
link between hypothalamic ER stress and leptin resistance [13]. To 
explore whether inhibition of ER stress could reverse the sensitivity 
of leptin, different approaches aimed at alleviating hypothalamic ER 
stress were conducted. Diet induced obese mice were treated with 
chaperones 4-phenylbutyrate (4-PBA) or tauroursodeoxycholic acid 
(TUDCA). The results showed normalization of the expression of ER 
stress, accompanied by enhanced leptin sensitivity and reduced food 
intake and body weight [56,109-112]. Furthermore, ER stress inducing 
reagents could inhibit leptin signaling by blocking the phosphorylation 
of STAT3 [113]. Research also found that ER stress leads to leptin 
resistance via the mediation of protein tyrosine phosphatase 1B 
(PTP1B) [112]. 
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Besides leptin resistance, ER stress may induce insulin resistance 
as well. The activation of JNK by ER stress could lead to increased 
serine phosphorylation of IRS. Phosphorylation of IRS at particular 
serine residues will disturb the interaction of IRS with InsR [114]. 
In addition, ER stress in pancreatic β-cells leads to β-cell apoptosis 
[115]. ER stress could also induce leptin/insulin resistance through 
elevated inflammation in the hypothalamus [55]. The mechanism of 
inflammation during the development of obesity will be discussed in 
the following section.
Hypothalamic inflammation and obesity
Continuous excessive nutrient exposure of the mitochondria 
could activate inflammatory pathways both in peripheral metabolic 
organs and in the CNS. Hypothalamic inflammation is characterized 
by increased interleukin and cytokine levels. For example, increased 
expression of the proinflammatory cytokines including IL-1, IL-6, and 
tumor necrosis factor alpha (TNFα), as well as the elevated expression 
of IKKβ, an important upstream kinase regulator of nuclear factor 
kappa–B (NF-κβ), were observed in the hypothalamus of obese rats 
[116,117]. 
Both lipid infusion and high-fat diet feeding could lead to obesity 
by activating hypothalamic inflammatory signaling pathways, which 
results in enhanced food intake and increased nutrient storage. 
Saturated fatty acids activate neuronal JNK and NF-κB signaling 
pathways, which directly impact leptin and insulin signaling [56]. 
The neuronal pro-inflammatory signaling could disturb intracellular 
signal transduction downstream of insulin receptors through the 
IRS phosphatidylinositol 3-kinase pathway [118]. Hypothalamic 
inflammation impairs leptin signaling via the JAK/STAT signaling 
pathway [119,120] and induces obesity by up-regulating molecules and 
pathways including an inhibitor of IKKβ, serine kinases, JNK, toll-like 
receptor 4 (TLR4), the ceramide biosynthesis pathway, and/or the ER 
stress pathway [121,122]. The induction of hypothalamic inflammation 
is associated with the activation of toll-like receptor (TLR) signaling 
[121]. Enhanced TLR expression activates JNK and IKK signaling and 
stimulates expression of inflammatory genes, such as TNFα and IL1β, 
which may be the main contributors to leptin resistance and insulin 
resistance. When TLR4 signaling was blocked, leptin resistance and 
insulin resistance were reversed [121]. 
Carotenoids, BCO2, and mitochondrial function
Carotenoids are a group of fat-soluble pigments derived from a 
40-carbon basal structure. They contain multiple conjugated double 
bonds and carry cyclic end-groups that can be substituted with oxygen-
containing groups. Based on chemical structure, carotenoids can be 
categorized into two classes: (1) carotenes, which contain only carbon 
and hydrogen atoms, and (2) oxocarotenoids (xanthophylls), which 
carry at least one oxygen atom [123]. 
Carotenoids are crucial for brain and visual function. Lutein and 
zeaxanthin are dominant carotenoids in human brain tissue, which 
account for 66-77% of total carotenoid concentration in the brain 
[124,125]. They are believed to prevent damage that leads to age-related 
macular degeneration by quenching free radicals and absorbing blue 
light [126,127]. Significant correlation between macular pigment density 
and global cognitive function was found in older adults [128,129]. It 
was reported that macular lutein and zeaxanthin were significantly 
correlated with their levels in brain tissue [130]. Therefore, macular 
pigment can also be used as the biomarker of lutein in brain tissue 
[131]. The brain is vulnerable to free radical attack because of the high 
metabolic activity, and high polyunsaturated fatty acid content. Lutein 
and zeaxanthin are the predominant carotenoids that are selectively 
taken up by human brain tissue throughout the lifetime that play an 
important neuro-protective role in brain function [132]. The most 
well-known benefit of carotenoids in brain function is improvement of 
cognitive function [131]. These carotenoids have also been suggested 
to modulate functional properties of synaptic membranes and to 
be involved in certain changes in the physiochemical and structural 
features of the membranes [133]. Most of these functions are attributed 
to their anti-oxidative and anti-inflammatory properties [131]. 
Considering the critical roles of carotenoids in the brain function, 
a well-regulated metabolism of carotenoids is necessary for brain, 
as well as the whole body health. BCO2 is mitochondrial enzyme 
involves in the cleavage of carotenoids. Compared to β-carotene-15, 
15’-monooxygenase (BCO1), BCO2 exhibits broader substrate 
specificity. It catalyzes asymmetric cleavage of both provitamin A 
and non-provitamin A carotenoids at the 9’, 10’ double bond to form 
β-ionone and β-apo-10’-carotenal [15]. The metabolites of carotenoids 
also exhibit important biological function. The activation of the NF-κB 
transcription system is associated with harmful effect to bone health, 
and contributes to cancer development. The 10,10′-diapocarotene-
10,10′-dial, which is the cleave products of lycopene by BCO2, was 
reported to inhibit NF-κB transcription system and to reduce the 
expression of NF-κB target genes [134]. Such process was mediated by 
the directly interaction of carotenoid derivatives with key kinases IKKβ 
and the p65 subunit. The fact that only the carotenoid derivatives, 
rather than the intact carotenoid exhibited inhibitory effect on NF-
κB highlights the critical role of BCO2 among the health benefits of 
carotenoids.
Previously, most research related to BCO2 was focused on the 
enzymatic function of BCO2. For example, Amengual et al. reported 
the deletion of BCO2 led to the disrupted carotenoid homeostasis 
accompanied by the elevated oxidative and reduced respiratory activity 
when mice were fed with carotenoids diet [23]. However, our lab’s recent 
studies found deletion of BCO2 gene in mice leads to increased appetite 
and higher risk to develop obesity, even when mice were fed with chow 
diet or high fat diet without containing carotenoids. This observation 
brings the possibility that BCO2 may play a more complicated role in 
maintaining mitochondrial function to modulate whole body energy 
homeostasis, rather than just exhibiting the enzymatic function. The 
proteomics and metabolomics analysis from our lab further revealed 
the perturbed energy metabolism, mitochondrial dysfunction, and 
elevated oxidative stress in hypothalamus caused by deletion of BCO2.
Conclusion and perspectives
The hypothalamus and mitochondria are two important centers 
for regulation of energy homeostasis at the organ and organelle levels, 
respectively. As the key organelle that maintains cellular energy 
metabolism, hypothalamic mitochondria participate in a variety of 
cell signaling pathways and modulate energy homeostasis through 
mitochondrial dynamics. Mitochondria is involved in the development 
of obesity via inadequate ATP production, enhanced inflammation, 
elevated oxidative stress, and ER stress. Therefore, the mitochondrial 
integrity is critical for energy homeostasis of the whole body and 
hypothalamus. Carotenoids in brain have been recently characterized. 
However the functions of carotenoids and the metabolites in 
hypothalamus are poorly understood.  
Considering the potential role of BCO2 in mitochondrial structure 
and function and the key position of the hypothalamus in energy 
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balance, BCO2 may play a novel function in maintaining metabolic 
homeostasis in hypothalamus through regulation of mitochondrial 
dynamics. However, the exact mechanism by which BCO2 mediates 
mitochondrial dynamics and hypothalamic function in regulation of 
energy balance remains unknown. Elucidating how BCO2 and the 
carotenoid metabolites protect mitochondrial activity and subsequently 
contribute to maintaining hypothalamic function will provide new 
perspectives for the prevention and treatment of obesity. 
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